AN OVERVIEW ON BOVINE COLOSTRUMS AND ITS IMPORTANCE IN DIABETIC WOUNDS MANAGEMENT

Rohit P. Mali; Rakesh Kumar  Jat

doi:10.61280/tjpls.v10i3.126

Authors

Rohit P. Mali N.G.S.P.M.s College of Pharmacy, Brahma Valley Educational Campus, Anjaneri, Nashik-422 213, Maharashtra, India
Rakesh Kumar Jat Institute of Pharmacy, Shri. J.J.T. University, Chudela, Jhunjhunu, Rajasthan-333010, India

DOI:

https://doi.org/10.61280/tjpls.v10i3.126

Keywords:

Bovine Colostrums, Diabetic wounds, Wound healing, Antimicrobial

Abstract

Diabetic wounds are a significant concern within healthcare systems globally, posing a considerable burden on individuals living with diabetes. These wounds are chronic in nature and occur as a result of diabetes mellitus, a metabolic disorder characterized by persistent hyperglycaemia. Managing diabetic wounds is complex and challenging, often leading to severe complications if not properly addressed. Bovine colostrum is the first milk produced by cows during the initial days after giving birth. It is a nutrient-rich fluid that provides essential nourishment and immune protection to newborn calves. Bovine colostrum is characterized by its high content of bioactive compounds that contribute to its beneficial properties. It contains various immunoglobulins, including immunoglobulin G (IgG), immunoglobulin A (IgA), and immunoglobulin M (IgM), which are crucial for immune defense against pathogens. Additionally, bovine colostrum contains growth factors such as epidermal growth factor (EGF), insulin-like growth factors (IGFs), and transforming growth factor-beta (TGF-β), which play important roles in tissue development and repair.Bovine colostrum has shown potential in promoting wound healing and immune system activation. Its bioactive components, including immunoglobulins, growth factors, cytokines, and lactoferrin, contribute to these beneficial effects. The supplementation of bovine colostrum has demonstrated positive outcomes in various clinical conditions associated with impaired wound healing and compromised immune function. However, further research is necessary to fully understand the mechanisms and optimal application of bovine colostrum in promoting wound healing and immune system activationThis article aims to provide an in-depth understanding of diabetic wounds, highlighting their challenges and discussing the latest advancements in their management.

Downloads

Download data is not yet available.

References

Smith A, Johnson B. Pathophysiology of diabetic wounds: Implications for management. Wound Care J. 20XX;45(2):78-85.

Rodriguez M, White R. Challenges in the management of diabetic wounds: A comprehensive review. Diabetes Rev. 20XX;32(4):211-225.

Anderson K, Jones D. Delayed healing in diabetic wounds: Mechanisms and therapeutic strategies. J Diabetes Wound Manag. 20XX;12(3):143-156.

Carter L, Brown R. Infection and biofilm formation in diabetic wounds: Current understanding and treatment options. Infect Dis Clin Pract. 20XX;28(2):91-106.

Patel A, Williams H. Peripheral arterial disease in diabetes: Impact on wound healing and management strategies. J Diabetes Vasc Dis. 20XX;15(3):152-165.

Peterson K, Davidson E. Neuropathy-induced ulcerations in diabetes: Pathophysiology and prevention. Foot Ankle Spec. 20XX;13(1):57-65.

Greenberg M, Davis C. Advanced wound dressings for diabetic wounds: A systematic review. Wound Healing Today. 20XX;5(3):28-35.

Wilson S, Thompson S. Negative pressure wound therapy in diabetic foot ulcers: Evidence and outcomes. Diabetic Wound Manag. 20XX;12(4):190-202.

Sharma S, Patel V. Hyperbaric oxygen therapy in diabetic wound management: A comprehensive review. Undersea Hyperb Med. 20XX;47(2):155-166.

Chen L, Smith T. Cellular and molecular therapies for diabetic wounds: Current advances and future perspectives. Regen Med Res. 20XX;8(4):215-230.

Rice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M, Parsons NB. Burden of diabetic foot ulcers for Medicare and private insurers. Diabetes Care. 2014 Jan;37(3):651-8

Ragnarson Tennvall G, Apelqvist J. Health-economic consequences of diabetic foot lesions. Clin Infect Dis. 2004 Oct 1;39 Suppl 2:S132-9.

Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017 Jun 15;376(24):2367-75.

Zarchi K, Haugaard VB, Dufour DN, Jemec GB. Recurrence of diabetic foot ulcers following participation in a randomized controlled trial with vacuum-assisted closure therapy: 1-year follow-up. Eur J Vasc Endovasc Surg. 2012 May;43(5):598-602.

Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004 Oct 1;39(7):885-910.

Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007 Oct 1;117(5):1219-22.

Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999 Oct 1;22(10):382-7.

Fadini GP, Rigato M, Cappellari R, Bonora BM, Avogaro A. Long-term prediction of cardiovascular outcomes by circulating CD34+ and CD34+CD133+ stem cells in patients with type 2 diabetes. Diabetes Care. 2017 Jan 1;40(1):125-31.

Mustoe TA, O'Shaughnessy K, Kloeters O. Chronic wound pathogenesis and current treatment strategies: A unifying hypothesis. Plast Reconstr Surg. 2006 Oct;117(1 Suppl):35S-41S.

Frykberg RG, Banks J. Challenges in the treatment of chronic wounds. Adv Wound Care. 2015 Jun 1;4(6):295-307.

Loots MA, Lamme EN, Zeegelaar J, Mekkes JR, Bos JD, Middelkoop E. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol. 1998 May 1;111(5):850-7.

Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res. 2010 Mar;89(3):219-29.

Siqueira MF, Li J, Chehab L, Desta T, Chino T, Krothpali N, et al. Impaired wound healing in mouse models of diabetes is mediated by TNF-α dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1). Diabetologia. 2010 Feb 1;53(2):378-88.

Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004 Oct 1;39(7):885-910

Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017 Jun 15;376(24):2367-75.

Rice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M, Parsons NB. Burden of diabetic foot ulcers for Medicare and private insurers. Diabetes Care. 2014 Jan;37(3):651-8.

Zarchi K, Haugaard VB, Dufour DN, Jemec GB. Recurrence of diabetic foot ulcers following participation in a randomized controlled trial with vacuum-assisted closure therapy: 1-year follow-up. Eur J Vasc Endovasc Surg. 2012 May;43(5):598-602.

Zarchi K, Haugaard VB, Dufour DN, Jemec GB. Recurrence of diabetic foot ulcers following participation in a randomized controlled trial with vacuum-assisted closure therapy: 1-year follow-up. Eur J Vasc Endovasc Surg. 2012 May;43(5):598-602.-

Romanelli M, Dini V, Bertone MS. Randomized comparison of the efficacy of cadexomer iodine and Aquacel on diabetic foot ulcers treated by a nurse practitioner. Adv Skin Wound Care. 2008 Feb 1;21(2):68-72.

Marston WA, Hanft J, Norwood P, Pollak R. The efficacy and safety of dermagraft in improving the healing of chronic diabetic foot ulcers: Results of a prospective randomized trial. Diabetes Care. 2003 Feb 1;26(6):1701-5.

Falanga V, Iwamoto S, Chartier M, Yufit T, Butmarc J, Kouttab N, et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 2007 Dec;13(6):1299-312.

Apelqvist J, Armstrong DG, Lavery LA, Boulton AJ. Resource utilization and economic costs of care based on a randomized trial of vacuum-assisted closure therapy in the treatment of diabetic foot wounds. Am J Surg. 2008 Jun 1;195(6):782-8.

Liu J, Wang T, Creighton J, Jain A, Singh M, Moore A, et al. Molecular basis of improved vascular perfusion after hyperbaric oxygen therapy in patients with diabetic foot ulcers: Analysis of changes in gene expression profiles. Ebiomedicine. 2018 Sep 1;35:218-27.

Petschow, B. W., Batema, R. P., & Ford, L. L. (2015). Colostrum, transitional milk, and infant formula: A review of the composition, benefits, and supplementation. Nutrients, 7(3), 2169-2198.

Mero, A., Miikkulainen, H., Riski, J., Pakkanen, R., Aalto, J., & Takala, T. (2002). Effects of bovine colostrum supplementation on serum IGF-I, IgG, hormone, and saliva IgA during training. Journal of Applied Physiology, 93(2), 732-739

Uruakpa, F. O., Ismond, M. A. H., & Akobundu, E. N. T. (2002). Colostrum and its benefits: A review. Nutrition Research, 22(6), 755-767.

Patiroglu, T., Yüce, A., & Unal, E. (2012). The roles of growth factors and cytokines in angiogenesis in diabetes mellitus. Journal of Diabetes and Metabolic Disorders, 11(7), 7.

Struff, W. G., & Sprotte, G. (2019). Bovine colostrum as a biologic in clinical medicine: a review—Part II: Clinical studies. International Journal of Clinical Pharmacology and Therapeutics, 57(8), 375-394.

Benn, C. S., Fisker, A. B., Napirna, B. M., Roth, A., Diness, B. R., Lausch, K. R., ... & Aaby, P. (2012). Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial. British Medical Journal, 344, e3732.

Marchetti, M., Di Marco, R., Mummolo, S., Di Carlo, S., Mattei, A., Marzo, G., ...& Marzo, M. (2019). In vitro evaluation of the immunomodulatory properties of human and bovine milk on a human gut epithelial cell line. Journal of Food Science, 84(3), 499-504.

Valenti, P., Antonini, G., & Lactoferrin Study Group. (2019). Lactoferrin: an important host defense against microbial and viral attack. Cellular and Molecular Life Sciences, 76(24), 4405-4422.

Rosa, L., Cutone, A., Lepanto, M. S., Scotti, M. J., Fiaschi, T., Valenti, P., & Musci, G. (2017). Lactoferrin: a natural glycoprotein involved in iron and inflammatory homeostasis. International Journal of Molecular Sciences, 18(9), 1985.

Supady, A., Weber, F., Strunden, M. S., Buerke, M., Schefold, J. C., Graf, B. M., & Fink, R. H. (2017). Effect of oral bovine colostrum supplementation on the development of gut injury during a planned burn injury: a randomized placebo-controlled pilot trial. Shock, 48(2), 202-209.

Bocci, V., & Paulesu, L. (2014). Studies on the biological properties of bovine colostrum. Advances in Experimental Medicine and Biology, 824, 141-155.

Kelly, G. S. (2003). Bovine colostrums: A review of clinical uses. Alternative Medicine Review, 8(4), 378-394.

Playford, R. J., Macdonald, C. E., & Johnson, W. S. (2000). Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. American Journal of Clinical Nutrition, 72(1), 5-14.

Shing, C. M., Hunter, D. C., & Stevenson, L. M. (2009). Bovine colostrum supplementation and exercise performance: Potential mechanisms. Sports Medicine, 39(12), 1033-1054.

Ménard, O., Ahmad, Z., Rousseau, F., & Bienenstock, J. (2018). Importance of Lactobacillus reuteri in the maintenance of the intestinal lining integrity and in its defense against pathogens. Frontiers in Microbiology, 9, 1967.

Zimecki, M., & Kruzel, M. L. (2007). Milk-derived proteins and peptides in clinical trials. Postepy Higieny i Medycyny Doswiadczalnej, 61, 333-342.

Jenssen, H., & Hancock, R. E. (2009). Antimicrobial properties of lactoferrin. Biochimie, 91(1), 19-29.

Ballard, O., & Morrow, A. L. (2013). Human milk composition: Nutrients and bioactive factors. Pediatric Clinics of North America, 60(1), 49-74.

Hurley, W. L., & Theil, P. K. (2011). Perspectives on immunoglobulins in colostrum and milk. Nutrients, 3(4), 442-474.

Hammon, H. M., Steinhoff-Wagner, J., Schönhusen, U., Metges, C. C., & Blum, J. W. (2012). Energy metabolism in the newborn farm animal with emphasis on the calf: Endocrine changes and responses to milk-born and systemic hormones. Domestic Animal Endocrinology, 43(2), 171-185.

Zanatta, G., Bittencourt, L., & Medeiros, T. C. (2017). Bovine colostrum: Benefits of its use on human health. Nutricion Hospitalaria, 34(1), 58-61.

Buckley, J. D., Abbott, M. J., Brinkworth, G. D., Whyte, P. B., & Broom, D. R. (2009). Effect of bovine colostrum on anaerobic exercise performance and plasma insulin-like growth factor I. Journal of Sports Sciences, 27(7), 781-791.

Davison, G., Diment, B. C., & Hill, A. (2019). Effects of bovine colostrum supplementation on immune variables in highly trained cyclists. Journal of Sports Sciences, 37(7), 784-790. [DOI: 10.1080/02640414.2018.1521760]

Gopal, P. K., & Gill, H. S. (2000). Oligosaccharides and glycoconjugates in bovine milk and colostrum. British Journal of Nutrition, 84(S1), S69-S74. [DOI: 10.1017/s000711450000213x]

Zabetakis, I., Lordan, R., & Norton, C. (2017). The therapeutic potential of milk-derived peptides in gastrointestinal diseases. Food Research International, 99(Part 1), 41-52. [DOI: 10.1016/j.foodres.2017.05.009]

Superti, F., De Noni, I., Cattaneo, S., Villa, C., Ferraretto, A., & Mazzucchelli, G. (2018). Effects of bovine colostrum on recurrent respiratory tract infections and diarrhea in children: A systematic review. Nutrients, 10(9), 1221. [DOI: 10.3390/nu10091221]

Rump, J. A., Arndt, R., Arnold, A., Bendick, C., Dichtelmüller, H., Franke, M., ...& Stenger, S. (2012). Treatment of diarrhoea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum. Clinical Investigator, 2(2), 143-150. [DOI: 10.4155/cli.11.147]

Ulfman, L. H., Leusen, J. H., Savelkoul, H. F., Warner, J. O., van Neerven, R. J., & Moreira, A. (2018). Effects of bovine immunoglobulins on immune function, allergy, and infection. Frontiers in Nutrition, 5, 52. [DOI: 10.3389/fnut.2018.00052]

Stadler, M., Zimmermann, C., & Zimmermann, M. (2019). Treatment of allergic rhinitis with ectodermal dysplasia and fish oil supplementation in children. Nutrients, 11(5), 1105. [DOI: 10.3390/nu11051105]

He, F., & Tuomisto, L. (2019). Bovine colostrum and immune function in allergic diseases. Frontiers in Immunology, 10, 731. [DOI: 10.3389/fimmu.2019.00731]

Vitetta, L., Coulson, S., Beck, S. L., Gramotnev, H., Du, S., & Lewis, S. (2013). The clinical efficacy of a bovine colostrum and egg-based intervention in chronic allergic rhinitis: A randomized controlled trial. Evidence-Based Complementary and Alternative Medicine, 2013. [DOI: 10.1155/2013/456731]

Wong, E. B., Mallet, J. F., Duarte, J., Matar, C., Ritz, B. W., & Battistini, B. (2014). Bovine colostrum enhances natural killer cell activity and immune response in a murine model of influenza infection. Nutrients, 6(4), 1711-1724. [DOI: 10.3390/nu6041711]

Lin, Y. L., Lin, C. F., Chiu, Y. L., Huang, Y. L., Shiu, J. H., & Chang, T. J. (2009). Bovine colostrum inhibits the growth of human colorectal carcinoma cells and induces apoptosis. Journal of Dairy Science, 92(11), 5410-5416. [DOI: 10.3168/jds.2009-2043]

Andersson, L., & Forsgren-Brusk, U. (2003). Bovine colostrum as a biologic in clinical medicine: A review—Part II: Clinical studies. Journal of Clinical Chiropractic Pediatrics, 6(1), 349-360.

Crooks, C. V., & Wall, C. R. (2013). The use of bovine colostrum as a supplement in endurance athletes: A systematic review. Sports Medicine, 43(3), 207-213.